STOCK TITAN

Apyx Medical (NASDAQ: APYX) director receives grant of 50,000 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Apyx Medical Corp director Wendy Lauren Levine received a grant of stock options as part of her compensation. She was awarded options to purchase 50,000 shares of Apyx common stock at an exercise price of $4.65 per share, expiring on June 11, 2036. According to the disclosure, the option grant vests ratably over a twelve-month period and becomes fully vested and exercisable on the first anniversary of the grant date. After this award, she holds 50,000 stock options directly.

Positive

  • None.

Negative

  • None.
Insider Levine Wendy Lauren
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Option to Buy) 50,000 $0.00 --
Holdings After Transaction: Stock Option (Option to Buy) — 50,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 50,000 options Stock Option (Option to Buy) grant on June 11, 2026
Exercise price $4.65 per share Conversion or exercise price of granted options
Underlying shares 50,000 shares Underlying common stock tied to the option grant
Expiration date June 11, 2036 Option expiration for this grant
Shares after transaction 50,000 options Total derivative holdings following this award
Vesting period 12 months Ratable vesting with full vesting at first anniversary
Stock Option (Option to Buy) financial
"security_title: "Stock Option (Option to Buy)""
exercise price financial
"conversion_or_exercise_price: "4.6500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"option which shall vest ratably over a twelve (12) month period"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-06-11T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Stock""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Levine Wendy Lauren

(Last)(First)(Middle)
C/O APYX MEDICAL CORPORATION
5115 ULMERTON ROAD

(Street)
CLEARWATER FLORIDA 33760

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Apyx Medical Corp [ APYX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Option to Buy)$4.6506/11/2026A50,000 (1)06/11/2036Common Stock50,000$050,000D
Explanation of Responses:
1. Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.
/s/ Wendy Levine06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Apyx Medical Corp (APYX) disclose in this Form 4 filing?

Apyx Medical Corp reported a stock option grant to director Wendy Lauren Levine. She received options on 50,000 shares of common stock as compensation, with specific vesting terms and a defined exercise price and expiration date disclosed in the filing.

How many stock options did Wendy Lauren Levine receive from APYX?

Wendy Lauren Levine received stock options for 50,000 underlying shares of Apyx Medical common stock. These options were granted as a compensation award and will vest over time, ultimately becoming fully exercisable on the first anniversary of the grant date.

What is the exercise price and expiration date of the APYX options granted?

The granted stock options have an exercise price of $4.65 per share and expire on June 11, 2036. This means she can choose to buy shares at $4.65 any time after vesting and before that expiration date, subject to the award’s terms.

How do the Apyx Medical options granted to Levine vest over time?

The stock option grant vests ratably over a twelve-month period and becomes fully vested and fully exercisable on the first anniversary of the grant date. This structure gradually earns her rights to the options across the year following the grant.

Is this APYX Form 4 transaction an open-market stock purchase or sale?

No, this Form 4 reflects a compensation-related stock option grant, not an open-market trade. The transaction code “A” and description show it is a grant or award acquisition, giving her the right to buy shares later at a fixed exercise price.

How many Apyx Medical stock options does Levine hold after this transaction?

After this grant, Wendy Lauren Levine is reported to hold 50,000 stock options directly. These options each relate to one share of Apyx Medical common stock and follow the vesting schedule and expiration date outlined in the Form 4 disclosure.